Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia - PubMed (original) (raw)
. 1997 Jun 4;89(11):796-802.
doi: 10.1093/jnci/89.11.796.
Affiliations
- PMID: 9182978
- DOI: 10.1093/jnci/89.11.796
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
L F Xi et al. J Natl Cancer Inst. 1997.
Abstract
Background: Epidemiologic studies have demonstrated strong and consistent associations between the detection of human papillomavirus (HPV) type 16 DNA and the risk of cervical intraepithelial neoplasia (CIN) and cervical cancer. However, HPV16 is also the most common type of HPV in the normal population, and only a minority of women with HPV16 infection develop cervical cancer. Studies of genomic heterogeneity in HPV16 have demonstrated the presence of multiple variant forms in all human populations examined to date. It is conceivable that the natural variants of HPV16 in a given population may not have the same biologic behavior.
Purpose: This study was designed to determine the association between natural variants of HPV16 and the risk of biopsy-confirmed CIN 2 or 3, the most important precancerous lesions of the uterine cervix.
Methods: Prospective studies were conducted among 1) women attending a university and 2) women presenting to a sexually transmitted disease clinic. Subjects were eligible for inclusion in this investigation if the initial cytologic findings did not reveal CIN 2-3 and HPV16 DNA was detected by means of a polymerase chain reaction (PCR)-based method in one or more cervical or vulvovaginal samples. Eligible subjects were followed every 4 months with cervical Pap smears and colposcopic examinations. Women were referred for biopsy if cytology or colposcopy suggested CIN 2-3. Two groups of HPV16 variants, prototype-like and nonprototype-like, were determined by means of single-strand conformation polymorphism (SSCP) analysis of PCR products from the noncoding region of the viral genome. Representative SSCP patterns from HPV16 variants were further characterized by direct DNA sequencing of the PCR products. Relative risks (RRs) and 95% confidence intervals (CIs) were calculated by Cox regression analysis.
Results: Prototype-like variants accounted for 79% of the HPV16 detected in university students and 86% of the virus detected in patients presenting to the sexually transmitted disease clinic. CIN 2-3 was confirmed by biopsy in nine of 57 HPV16-positive women attending the university and in 10 of 66 HPV16-positive women presenting to the sexually transmitted disease clinic. Among university students, those with HPV16 nonprototype-like variants were 6.5 (95% CI = 1.6-27.2) times more likely to develop CIN 2-3 than those with prototype-like variants. A similar association was observed among women presenting to the sexually transmitted disease clinic (RR = 4.5; 95% CI = 0.9-23.8).
Conclusions: This study suggests that the risk of developing CIN 2-3 is not the same with all variants of HPV16 and that nonprototype-like variants confer a greater risk compared with prototype-like variants. The important genomic differences underlying this increased risk of CIN 2-3 remain to be determined.
Comment in
- Human papillomavirus variants: implications for natural history studies and vaccine development efforts.
Hildesheim A. Hildesheim A. J Natl Cancer Inst. 1997 Jun 4;89(11):752-3. doi: 10.1093/jnci/89.11.752. J Natl Cancer Inst. 1997. PMID: 9182967 No abstract available.
Similar articles
- Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF. Hudelist G, et al. Gynecol Oncol. 2004 Mar;92(3):873-80. doi: 10.1016/j.ygyno.2003.11.035. Gynecol Oncol. 2004. PMID: 14984955 - Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students.
Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, Adam DE, Kiviat NB, Koutsky LA. Xi LF, et al. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):343-51. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927494 - Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. Swan DC, et al. J Clin Microbiol. 1999 Apr;37(4):1030-4. doi: 10.1128/JCM.37.4.1030-1034.1999. J Clin Microbiol. 1999. PMID: 10074522 Free PMC article. - Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV).
Syrjänen KJ. Syrjänen KJ. Eur J Obstet Gynecol Reprod Biol. 1996 Mar;65(1):45-53. doi: 10.1016/0028-2243(95)02303-a. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8706956 Review. - A review of the natural history of cervical intraepithelial neoplasia.
Duggan MA. Duggan MA. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:176-93. Gan To Kagaku Ryoho. 2002. PMID: 11890103 Review.
Cited by
- Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.
Tachezy R, Mikysková I, Ludvíková V, Rob L, Kucera T, Slavík V, Beková A, Robová H, Pluta M, Hamsíková E. Tachezy R, et al. Eur J Clin Microbiol Infect Dis. 2006 Aug;25(8):492-500. doi: 10.1007/s10096-006-0172-5. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16896828 - Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.
Watts KJ, Thompson CH, Cossart YE, Rose BR. Watts KJ, et al. J Clin Microbiol. 2001 May;39(5):2009-14. doi: 10.1128/JCM.39.5.2009-2014.2001. J Clin Microbiol. 2001. PMID: 11326037 Free PMC article. - Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico.
López-Revilla R, Pineda MA, Ortiz-Valdez J, Sánchez-Garza M, Riego L. López-Revilla R, et al. Infect Agent Cancer. 2009 Feb 16;4:3. doi: 10.1186/1750-9378-4-3. Infect Agent Cancer. 2009. PMID: 19216802 Free PMC article. - Evolutionary and biophysical relationships among the papillomavirus E2 proteins.
Blakaj DM, Fernandez-Fuentes N, Chen Z, Hegde R, Fiser A, Burk RD, Brenowitz M. Blakaj DM, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(3):900-17. doi: 10.2741/3285. Front Biosci (Landmark Ed). 2009. PMID: 19273107 Free PMC article. Review.